Zeon Lifesciences unveils revolutionary liquid-filled capsules
These capsules deliver optimal levels of active ingredients, leading to maximum efficacy and more immediate results
Zeon Lifesciences has launched liquid-filled capsules. This one-of-its-kind of capsules offer a cutting-edge and unique delivery system enclosing a host of advantages including enhanced bioavailability and absorption rates. It also ensures precise and consistent dosages empowering individuals to have better control over the administration of Zeon's products.
Harnessing advanced, one-of-a-kind technologies, these capsules deliver optimal levels of active ingredients, leading to maximum efficacy and more immediate results.
Zeon has partnered with Collaborative Third-Party Manufacturing for innovative liquid-filled capsules. The trend-setting delivery mechanism revolutionises the industry by delivering multiple benefits that enhance the overall experience for consumers.
"This exemplary advancement illustrates Zeon's persistent quest for excellence, driving the nutraceutical industry into unexplored domains. Ever since our inception, we have carved a distinctive reputation as a pioneer in innovation and technology advancement and the liquid-filled capsules are a testament to this legacy. Leveraging our distinctive collaboration, we will continue to innovate and set new benchmarks and trends in the nutraceutical industry for consumers to reap maximum health benefits,'' said Suresh Garg, CMD and Founder, Zeon Lifesciences.
“I am thrilled to be part of a team that is revolutionising drug delivery. Our liquid-filled capsules are a game-changer in the pharmaceutical industry, offering a host of unmatched benefits. From enhanced bioavailability to improved patient compliance, these capsules are poised to disrupt the status quo and elevate the standard of care. I am excited to witness the positive impact they will have on patient outcomes and overall healthcare,” Dr Vivek Srivastav, Senior VP, innovation business strategy and scientific affairs, Zeon Lifesciences.